Why it was recalled
TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.
Product description
Trulicity (dulaglutide) injection, 1.5 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 00002-1434-80
Lot numbers, UPCs & expiration codes
Lot #: D482749A, Exp: 10/15/2023.
Where it was sold
NM only
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0883-2022
- Classification
- Class II
- Status
- Completed
- Recall initiated
- Apr 5, 2022
- FDA report date
- May 25, 2022
- Quantity
- 1 box
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Cardinal Health Inc.
Original FDA data
Every field from FDA enforcement report D-0883-2022, exactly as published.
Show all FDA fields
- City
- Dublin
- State
- OH
- Status
- Completed
- Country
- United States
- Event ID
- 89976
- Address
- 7000 Cardinal Pl
- Code information
- Lot #: D482749A, Exp: 10/15/2023.
- Postal code
- 43017-1091
- Report date
- May 25, 2022
- Product type
- Drugs
- Recall number
- D-0883-2022
- Classification
- Class II
- Recalling firm
- Cardinal Health Inc.
- Product quantity
- 1 box
- Reason for recall
- TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Trulicity (dulaglutide) injection, 1.5 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 00002-1434-80
- Distribution pattern
- NM only
- Recall initiation date
- Apr 5, 2022
- Initial firm notification
- Letter
- Center classification date
- May 19, 2022